In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET

by Peter K. Wong, Sze Ting Lee, Carmel Murone, John Eng, Nathan Lawrentschuk, Salvatore U. Berlangieri, Kunthi Pathmaraj, Graeme J. O'Keefe, John Sachinidis, Amanda J. Byrne, Damien M. Bolton, Ian D. Davis, Andrew M. Scott
Published 2014-05-01

FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET

by Patrick Martineau, Matthieu Pelletier-Galarneau, Daniel Juneau, Eugene Leung, Pablo Nery, Rob deKemp, Rob Beanlands, David Birnie
Published 2020-12-01

Pilot study assessing 18F-fluorothymidine PET/CT in cervical and vaginal cancers before and after external beam radiation

by Linda P. Cho, Chun K. Kim, Akila N. Viswanathan
Published 2015-11-01

FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab

by Matthew Scarpelli, Christopher Zahm, Scott Perlman, Douglas G. McNeel, Robert Jeraj, Glenn Liu
Published 2019-01-01

[18F]-fluoro-l-thymidine PET and advanced MRI for preoperative grading of gliomas

by S. Collet, S. Valable, J.M. Constans, E. Lechapt-Zalcman, S. Roussel, N. Delcroix, A. Abbas, M. Ibazizene, M. Bernaudin, L. Barré, J.M. Derlon, J.S. Guillamo
Published 2015-01-01

18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-oppo...

by Perrin E. Romine, Lanell M. Peterson, Brenda F. Kurland, Darrin W. Byrd, Alena Novakova-Jiresova, Mark Muzi, Jennifer M. Specht, Robert K. Doot, Jeanne M. Link, Kenneth A. Krohn, Paul E. Kinahan, David A. Mankoff, Hannah M. Linden
Published 2021-08-01

Impact of [¹⁸F]FDG-PET and [¹⁸F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer

by Tine N. Christensen, Seppo W. Langer, Gitte Persson, Klaus Richter Larsen, Annemarie G. Amtoft, Sune H. Keller, Andreas Kjaer, Barbara Malene Fischer
Published 2021-02-01

FLT-PET for early response evaluation of colorectal cancer patients with liver metastases: a prospective study

by Marie Benzon Mogensen, Annika Loft, Marianne Aznar, Thomas Axelsen, Ben Vainer, Kell Osterlind, Andreas Kjaer
Published 2017-07-01

18F-fluorothymidine (FLT)-PET and diffusion-weighted MRI for early response evaluation in patients with small cell lung cancer: a pilot study

by Tine Nøhr Christensen, Seppo W. Langer, Katrine Engholm Villumsen, Helle Hjorth Johannesen, Johan Löfgren, Sune Høgild Keller, Adam Espe Hansen, Andreas Kjaer, Barbara Malene Fischer
Published 2020-01-01

Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine (¹⁸F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study

by Kalevi Kairemo, Elmer B. Santos, Homer A. Macapinlac, Shreyaskumar Patel, Anthony P. Conley, David S. Hong, Vivek Subbiah
Published 2020-02-01

Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine (¹⁸F-FLT) PET/CT in Lung Cancer

by Kalevi Kairemo, Elmer B. Santos, Homer A. Macapinlac, Vivek Subbiah
Published 2020-01-01